VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: EyeDrMike who wrote (7428)	4/24/1998 7:49:00 PM
From: blankmind	Read Replies (3) of 23519

- Can't believe the Motley Fool Board... - They've concluded that Vivus won't sell because it's harder to take than Viagra. - But without the Scripts data, how do they know? ÿ MOTLEYÿ FOOL ÿÿ-ÿApr 24 7:48pm MOTLEY FOOL \| THESTREET.COM \| ISDEX \| ONLINE INVESTOR \| FINANCE HOME Help LUNCHTIME \| EVENING \| FOOL FOUR \| DOUBLE \| TROUBLE \| CONF CALLS ------------------------------------------------------------------------ ------------------------------------------------------------------------ Apr 24, 1998 (6:35 PM ET) - The Motley Fool Evening News Vivus Inc. (Nasdaq:VVUS - news) surged $1 1/4 to $12 3/4 as the most actively traded company on the Nasdaq today, trading more than 17 million shares on speculation that its male impotence treatment Muse will benefit on the coattails of Pfizer's (NYSE:PFE - news) new drug Viagra. Regional brokerage Cruttenden Roth yesterday raised its rating on Vivus, which was trading at $8 on Wednesday, to a "strong buy" with a 1998 price target of $23 a share, arguing that patients with erectile dysfunction who find Viagra ineffective may opt to try Muse instead. The problem is that comparing Viagra to Muse is like comparing apples to oranges. While Viagra is essentially a blue, easy-to-swallow pill, Muse is a single-use plastic applicator containing a micro-suppository of alprostadil, a drug that increases penile blood flow that is inserted about an inch into the urethra where the medication is released. It's easy to see why Viagra would be preferred over Muse despite the fact Viagra is best at treating mild to moderate impotence and may cause side effects such as headaches and dizziness. Investors who drove up Vivus today seemed to forget that Vivus reported a worse-than-expected Q1 loss of $0.07 a share, down from a profit of $0.27 for the year-earlier period.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next